ClinicalTrials.govpublic full text
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier
herpes zoster
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 623544
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.